Filed: 2/13/2026ACC: 0002050194-26-000001
📋 What this filing means
SPRUCE STREET CAPITAL LP filed this quarterly 13F‑HR report disclosing 27 equity positions with a total reported market value of $302.66M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
27
Positions
$302.66M
Total AUM (reported)
30.90M
Total Shares
Allocation by class
COM$141.40M46.7%
COM NEW$107.52M35.5%
COM SHS$27.23M9.0%
ORD SHS CL A$17.94M5.9%
SPONSORED ADS$8.57M2.8%
Portfolio Concentration
Top 3$98.94M32.7%
4–10$115.35M38.1%
11–25$86.08M28.4%
Rest$2.29M0.8%
Top 3 weight
32.7%
Top 10 weight
70.8%
Voting Authority Distribution
Total shares with voting rights: 30.90M
Sole
Full voting authority
30.90M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole27
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings27
Rows:
CIDARA THERAPEUTICS INC
SOLEShares232.27K
TypeSH
Market value$51.31M
16.95%
Sole
232.27K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares2.98M
TypeSH
Market value$25.25M
8.34%
Sole
2.98M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares1.01M
TypeSH
Market value$22.38M
7.40%
Sole
1.01M
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares4.09M
TypeSH
Market value$19.74M
6.52%
Sole
4.09M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares400.36K
TypeSH
Market value$18.47M
6.10%
Sole
400.36K
Shared
0.00
None
0.00
KINIKSA PHARMACEUTICALS INTL
SOLEShares434.98K
TypeSH
Market value$17.94M
5.93%
Sole
434.98K
Shared
0.00
None
0.00
EYEPOINT INC
SOLEShares981.54K
TypeSH
Market value$17.93M
5.93%
Sole
981.54K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares2.41M
TypeSH
Market value$14.54M
4.80%
Sole
2.41M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares3.89M
TypeSH
Market value$14.47M
4.78%
Sole
3.89M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares297.44K
TypeSH
Market value$12.26M
4.05%
Sole
297.44K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares432.04K
TypeSH
Market value$9.76M
3.23%
Sole
432.04K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares784K
TypeSH
Market value$9.52M
3.14%
Sole
784K
Shared
0.00
None
0.00
SAB BIOTHERAPEUTICS INC
SOLEShares2.20M
TypeSH
Market value$8.22M
2.72%
Sole
2.20M
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares3.58M
TypeSH
Market value$7.34M
2.43%
Sole
3.58M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares446.08K
TypeSH
Market value$6.87M
2.27%
Sole
446.08K
Shared
0.00
None
0.00
MINERVA NEUROSCIENCES INC
SOLEShares1.66M
TypeSH
Market value$6.66M
2.20%
Sole
1.66M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares49.12K
TypeSH
Market value$6.62M
2.19%
Sole
49.12K
Shared
0.00
None
0.00
CYBIN INC
SOLEShares770K
TypeSH
Market value$6.30M
2.08%
Sole
770K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares387.97K
TypeSH
Market value$6.27M
2.07%
Sole
387.97K
Shared
0.00
None
0.00
ENANTA PHARMACEUTICALS INC
SOLEShares389.69K
TypeSH
Market value$6.15M
2.03%
Sole
389.69K
Shared
0.00
None
0.00
ALTO NEUROSCIENCE INC
SOLEShares222.84K
TypeSH
Market value$3.97M
1.31%
Sole
222.84K
Shared
0.00
None
0.00
ATHIRA PHARMA INC
SOLEShares393.70K
TypeSH
Market value$2.98M
0.98%
Sole
393.70K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares78K
TypeSH
Market value$1.95M
0.64%
Sole
78K
Shared
0.00
None
0.00
ALECTOR INC
SOLEShares1.12M
TypeSH
Market value$1.74M
0.58%
Sole
1.12M
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares175K
TypeSH
Market value$1.74M
0.57%
Sole
175K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CIDARA THERAPEUTICS INCSOLE | COM NEW | 232.27K | SH | $51.31M 16.95% | 232.27K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 2.98M | SH | $25.25M 8.34% | 2.98M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.01M | SH | $22.38M 7.40% | 1.01M | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 4.09M | SH | $19.74M 6.52% | 4.09M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 400.36K | SH | $18.47M 6.10% | 400.36K | 0.00 | 0.00 |
KINIKSA PHARMACEUTICALS INTLSOLE | ORD SHS CL A | 434.98K | SH | $17.94M 5.93% | 434.98K | 0.00 | 0.00 |
EYEPOINT INCSOLE | COM NEW | 981.54K | SH | $17.93M 5.93% | 981.54K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 2.41M | SH | $14.54M 4.80% | 2.41M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 3.89M | SH | $14.47M 4.78% | 3.89M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 297.44K | SH | $12.26M 4.05% | 297.44K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 432.04K | SH | $9.76M 3.23% | 432.04K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 784K | SH | $9.52M 3.14% | 784K | 0.00 | 0.00 |
SAB BIOTHERAPEUTICS INCSOLE | COM NEW | 2.20M | SH | $8.22M 2.72% | 2.20M | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 3.58M | SH | $7.34M 2.43% | 3.58M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 446.08K | SH | $6.87M 2.27% | 446.08K | 0.00 | 0.00 |
MINERVA NEUROSCIENCES INCSOLE | COM NEW | 1.66M | SH | $6.66M 2.20% | 1.66M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 49.12K | SH | $6.62M 2.19% | 49.12K | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 770K | SH | $6.30M 2.08% | 770K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 387.97K | SH | $6.27M 2.07% | 387.97K | 0.00 | 0.00 |
ENANTA PHARMACEUTICALS INCSOLE | COM | 389.69K | SH | $6.15M 2.03% | 389.69K | 0.00 | 0.00 |
ALTO NEUROSCIENCE INCSOLE | COM SHS | 222.84K | SH | $3.97M 1.31% | 222.84K | 0.00 | 0.00 |
ATHIRA PHARMA INCSOLE | COM | 393.70K | SH | $2.98M 0.98% | 393.70K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 78K | SH | $1.95M 0.64% | 78K | 0.00 | 0.00 |
ALECTOR INCSOLE | COM | 1.12M | SH | $1.74M 0.58% | 1.12M | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 175K | SH | $1.74M 0.57% | 175K | 0.00 | 0.00 |
Page 1 of 2